Nifty

:

25722.10

Sensex

:

83938.71

-155.75 (-0.60%)
-465.75 (-0.55%)

Login

Nifty
Sensex

:
:

25722.10
83938.71

-155.75 (-0.60%)
-465.75 (-0.55%)

Panacea Biotec Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

54/99

BSE: 531349 | NSE: PANACEABIO

Watchlist

NSE BSE

437.90

31-Oct-2025

Open
High
Low
Previous Close

441.55
444.4
436.5
441.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

40822
17945863.15
581.9
281.1

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,681.25
233.56
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,596.49
N/A
3.20

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-1.54
-2.20
6.72

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-23.35

PAT CAGR (%)

10 Years
5 Years
3 Years

-7.63
-43.57
-36.85

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

0.87
4.24
1.81

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-239.51
-386.11
-622.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 112.25 56.88 97.35% 67.90 80.37 -15.52% 108.43 95.23 13.86% 76.64 94.59 -18.98%
Expenses 115.27 67.37 71.10% 86.47 89.61 -3.50% 93.04 88.59 5.02% 69.90 84.63 -17.41%
EBITDA -3.02 -10.49 - -18.57 -9.24 - 15.39 6.64 131.78% 6.74 9.96 -32.33%
EBIDTM -2.69% -18.44% -27.35% -11.50% 14.19% 6.97% 8.79% 10.53%
Other Income 4.95 3.80 30.26% 6.09 16.39 -62.84% 3.32 3.05 8.85% 3.41 2.13 60.09%
Interest 6.00 3.21 86.92% 4.64 3.36 38.10% 3.85 3.41 12.90% 3.76 3.55 5.92%
Depreciation 4.77 5.08 -6.10% 4.91 5.14 -4.47% 5.21 5.21 0.00% 5.09 5.34 -4.68%
PBT -8.84 -14.98 - -22.03 -1.35 - 9.65 1.07 801.87% 1.30 3.20 -59.38%
Tax -2.14 -1.20 - -9.64 0.02 - 0.00 0.64 -100.00% 0.01 0.00 0
PAT -6.70 -13.78 - -12.39 -1.37 - 9.65 0.43 2,144.19% 1.29 3.20 -59.69%
PATM -5.97% -24.23% -18.25% -1.70% 8.90% 0.45% 1.68% 3.38%
EPS -1.09 -2.25 - -2.02 -0.22 - 1.57 0.07 2,142.86% 0.21 0.52 -59.62%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 166.70 115.72 44.05% 132.53 136.46 -2.88% 163.49 150.50 8.63% 147.35 143.02 3.03%
Expenses 167.88 129.71 29.43% 159.41 142.50 11.87% 155.53 150.65 3.24% 140.35 146.58 -4.25%
EBITDA -1.18 -13.99 - -26.88 -6.04 - 7.96 -0.15 - 7.00 -3.56 -
EBIDTM -0.71% -12.09% -20.28% -4.43% 4.87% -0.10% 4.75% -2.49%
Other Income 5.67 3.80 49.21% 8.59 10.81 -20.54% 3.62 5.68 -36.27% 4.65 3.23 43.96%
Interest 0.86 0.87 -1.15% 1.04 0.82 26.83% 0.99 0.85 16.47% 0.98 0.91 7.69%
Depreciation 8.39 8.73 -3.89% 8.42 8.81 -4.43% 8.98 9.11 -1.43% 8.68 9.31 -6.77%
PBT 6.56 -17.05 - -0.04 -2.12 - 4.38 -1.65 - 4.76 -7.78 -
Tax 2.60 -1.17 - 1.95 -0.13 - -0.06 0.55 - 0.05 0.51 -90.20%
PAT 3.96 -15.88 - -1.99 -1.99 - 4.44 -2.20 - 4.71 -8.29 -
PATM 2.38% -13.72% -1.50% -1.46% 2.72% -1.46% 3.20% -5.80%
EPS 0.66 -2.58 - -0.31 -0.23 - 0.74 -0.37 - 0.78 -1.37 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 365.22 309.86 359.60 257.07 235.50 343.56 489.68 444.16 574.19 530.09 646.90 Net Sales Growth 11.66% -13.83% 39.88% 9.16% -31.45% -29.84% 10.25% -22.65% 8.32% -18.06% Cost Of Goods Sold 145.18 102.70 141.69 163.06 112.09 176.26 150.72 179.70 197.00 168.83 214.35 Gross Profit 220.04 207.15 217.92 94.01 123.42 167.29 338.96 264.46 377.19 361.25 432.55 GP Margin 60.25% 66.85% 60.60% 36.57% 52.41% 48.69% 69.22% 59.54% 65.69% 68.15% 66.87% Total Expenditure 364.68 316.79 345.44 319.69 308.17 343.07 479.63 590.77 492.76 460.60 534.39 Power & Fuel Cost - 28.46 25.33 22.43 26.51 20.78 17.58 22.72 20.94 28.08 24.38 % Of Sales - 9.18% 7.04% 8.73% 11.26% 6.05% 3.59% 5.12% 3.65% 5.30% 3.77% Employee Cost - 97.02 86.53 71.03 72.50 59.47 123.24 141.94 136.74 132.21 139.80 % Of Sales - 31.31% 24.06% 27.63% 30.79% 17.31% 25.17% 31.96% 23.81% 24.94% 21.61% Manufacturing Exp. - 40.00 41.98 27.52 52.73 22.20 14.41 17.46 14.71 34.76 39.10 % Of Sales - 12.91% 11.67% 10.71% 22.39% 6.46% 2.94% 3.93% 2.56% 6.56% 6.04% General & Admin Exp. - 26.71 24.20 18.67 23.59 25.46 15.31 13.95 11.29 36.05 49.77 % Of Sales - 8.62% 6.73% 7.26% 10.02% 7.41% 3.13% 3.14% 1.97% 6.80% 7.69% Selling & Distn. Exp. - 9.84 10.71 12.81 9.26 28.18 10.00 4.09 5.66 36.74 43.79 % Of Sales - 3.18% 2.98% 4.98% 3.93% 8.20% 2.04% 0.92% 0.99% 6.93% 6.77% Miscellaneous Exp. - 12.05 15.01 4.17 11.50 10.71 148.38 210.91 106.42 23.93 43.79 % Of Sales - 3.89% 4.17% 1.62% 4.88% 3.12% 30.30% 47.49% 18.53% 4.51% 3.59% EBITDA 0.54 -6.93 14.16 -62.62 -72.67 0.49 10.05 -146.61 81.43 69.49 112.51 EBITDA Margin 0.15% -2.24% 3.94% -24.36% -30.86% 0.14% 2.05% -33.01% 14.18% 13.11% 17.39% Other Income 17.77 16.62 24.91 34.44 12.57 20.75 43.91 8.12 17.62 53.66 25.56 Interest 18.25 15.46 13.78 10.06 7.04 7.52 147.25 104.63 103.23 103.50 115.00 Depreciation 19.98 20.29 21.09 24.50 26.43 26.57 27.29 53.71 57.05 66.15 71.32 PBT -19.92 -26.06 4.21 -62.75 -93.58 -12.85 -120.57 -296.83 -61.23 -46.50 -48.25 Tax -11.77 -10.83 0.66 24.79 0.00 1.56 17.10 10.61 10.64 -11.38 0.53 Tax Rate 59.09% 41.56% 15.68% -39.51% 0.00% -12.14% -12.58% 28.54% -17.38% 13.54% 37.86% PAT -8.15 -15.23 3.55 -87.54 -93.58 -14.41 -153.07 26.57 -71.88 -72.66 0.87 PAT before Minority Interest -8.15 -15.23 3.55 -87.54 -93.58 -14.41 -153.07 26.57 -71.88 -72.66 0.87 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -2.23% -4.92% 0.99% -34.05% -39.74% -4.19% -31.26% 5.98% -12.52% -13.71% 0.13% PAT Growth 0.00% - - - - - - - - - EPS -1.33 -2.48 0.58 -14.28 -15.27 -2.35 -24.97 4.33 -11.73 -11.85 0.14

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 610.07 559.09 559.17 459.95 661.23 624.80 544.06 456.70 592.79 544.01 653.08 Net Sales Growth 11.80% -0.01% 21.57% -30.44% 5.83% 14.84% 19.13% -22.96% 8.97% -16.70% Cost Of Goods Sold 235.04 199.54 230.12 252.66 262.20 204.63 156.79 172.24 187.25 149.52 215.81 Gross Profit 375.03 359.56 329.04 207.29 399.03 420.17 387.27 284.45 405.55 394.50 437.27 GP Margin 61.47% 64.31% 58.84% 45.07% 60.35% 67.25% 71.18% 62.28% 68.41% 72.52% 66.96% Total Expenditure 623.17 585.01 579.23 557.90 674.43 548.18 518.57 589.83 508.26 496.89 541.37 Power & Fuel Cost - 38.93 35.95 31.95 37.82 30.94 29.74 34.55 33.52 30.55 25.15 % Of Sales - 6.96% 6.43% 6.95% 5.72% 4.95% 5.47% 7.57% 5.65% 5.62% 3.85% Employee Cost - 173.05 149.57 126.48 182.97 156.17 144.42 147.08 151.59 148.12 142.02 % Of Sales - 30.95% 26.75% 27.50% 27.67% 25.00% 26.54% 32.20% 25.57% 27.23% 21.75% Manufacturing Exp. - 64.83 68.25 47.24 78.70 43.22 33.38 44.31 40.05 41.88 39.47 % Of Sales - 11.60% 12.21% 10.27% 11.90% 6.92% 6.14% 9.70% 6.76% 7.70% 6.04% General & Admin Exp. - 35.75 31.38 43.77 53.79 47.48 54.20 71.07 40.39 52.98 39.41 % Of Sales - 6.39% 5.61% 9.52% 8.13% 7.60% 9.96% 15.56% 6.81% 9.74% 6.03% Selling & Distn. Exp. - 36.94 28.52 42.70 48.08 51.18 42.81 31.27 36.98 37.70 44.20 % Of Sales - 6.61% 5.10% 9.28% 7.27% 8.19% 7.87% 6.85% 6.24% 6.93% 6.77% Miscellaneous Exp. - 35.97 35.43 13.10 10.86 14.56 57.24 89.31 18.48 36.14 44.20 % Of Sales - 6.43% 6.34% 2.85% 1.64% 2.33% 10.52% 19.56% 3.12% 6.64% 5.41% EBITDA -13.10 -25.92 -20.06 -97.95 -13.20 76.62 25.49 -133.13 84.53 47.12 111.71 EBITDA Margin -2.15% -4.64% -3.59% -21.30% -2.00% 12.26% 4.69% -29.15% 14.26% 8.66% 17.11% Other Income 22.53 20.66 25.80 51.66 10.97 9.98 30.35 5.06 8.23 46.59 20.35 Interest 3.87 3.88 3.58 4.44 180.84 185.34 173.98 104.83 100.58 100.93 127.33 Depreciation 34.47 34.81 36.71 39.12 43.78 45.59 44.13 55.03 58.53 67.95 73.32 PBT 15.66 -43.94 -34.56 -89.86 -226.85 -144.32 -162.28 -287.93 -66.35 -75.17 -68.59 Tax 4.54 0.77 2.98 46.55 371.02 1.96 16.95 8.56 9.86 -10.98 1.92 Tax Rate 28.99% -9.69% 202.72% 363.67% 25.60% -1.36% -9.54% 18.58% -14.86% 16.28% -10.14% PAT 11.12 -8.37 -1.17 -33.23 1,078.31 -146.24 -194.60 37.58 -74.18 -54.75 -18.51 PAT before Minority Interest 11.48 -8.72 -1.50 -33.74 1,078.33 -146.20 -194.63 37.52 -76.20 -56.47 -20.85 Minority Interest 0.36 0.35 0.33 0.51 -0.02 -0.04 0.03 0.06 2.02 1.72 2.34 PAT Margin 1.82% -1.50% -0.21% -7.22% 163.08% -23.41% -35.77% 8.23% -12.51% -10.06% -2.83% PAT Growth 139.21% - - - - - - - - - EPS 1.81 -1.37 -0.19 -5.42 175.91 -23.86 -31.75 6.13 -12.10 -8.93 -3.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 313.97 329.14 325.65 415.09 508.17 892.73 418.47 388.10 455.82 540.03 Share Capital 6.13 6.13 6.13 6.13 6.13 6.13 6.13 6.13 6.13 22.43 Total Reserves 307.84 323.02 319.53 408.97 502.04 854.61 412.35 381.97 449.69 517.60 Non-Current Liabilities 215.58 346.99 316.77 271.46 254.07 247.15 253.46 748.33 874.35 963.59 Secured Loans 0.00 0.00 0.18 0.24 2.05 6.35 8.90 561.25 704.57 777.88 Unsecured Loans 160.51 124.87 102.22 83.87 60.03 54.08 79.41 9.46 9.49 1.00 Long Term Provisions 31.43 187.29 184.17 184.77 183.84 182.75 183.68 195.31 187.39 184.37 Current Liabilities 351.40 249.14 250.85 244.16 199.52 167.35 921.09 685.27 589.90 474.00 Trade Payables 164.83 116.14 129.12 144.94 124.06 135.90 77.88 241.84 226.75 173.50 Other Current Liabilities 87.70 103.03 92.99 70.35 71.02 24.79 764.16 242.81 142.05 80.88 Short Term Borrowings 67.94 0.00 0.00 0.00 0.00 3.57 69.39 193.82 219.65 218.25 Short Term Provisions 30.93 29.97 28.74 28.86 4.44 3.10 9.66 6.79 1.45 1.37 Total Liabilities 880.95 925.27 893.27 930.71 961.76 1,307.23 1,593.02 1,821.70 1,920.07 1,977.62 Net Block 348.06 357.26 385.31 416.13 398.44 447.29 496.44 890.93 942.01 987.58 Gross Block 836.66 826.93 852.15 865.20 826.40 863.64 1,087.87 1,542.55 1,536.97 1,518.16 Accumulated Depreciation 488.59 469.67 466.84 449.07 427.96 416.36 591.43 651.62 594.95 530.58 Non Current Assets 587.22 741.77 690.25 644.49 669.21 692.91 676.91 1,468.04 1,510.70 1,636.51 Capital Work in Progress 119.04 96.54 27.85 0.88 12.97 3.74 3.10 37.16 27.68 19.01 Non Current Investment 0.27 0.27 0.27 0.27 0.27 54.53 2.54 344.88 344.88 394.66 Long Term Loans & Adv. 51.30 221.39 225.33 188.82 187.45 186.50 173.95 194.69 195.57 234.01 Other Non Current Assets 0.32 0.55 1.44 0.49 4.27 0.85 0.89 0.39 0.55 1.25 Current Assets 293.73 183.49 199.13 248.83 292.55 614.32 916.11 353.65 409.37 341.11 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 152.10 107.93 116.10 129.25 87.04 99.23 42.51 149.09 140.60 136.57 Sundry Debtors 20.85 11.08 12.27 23.32 35.29 17.69 25.20 142.27 175.80 142.21 Cash & Bank 62.16 11.96 43.25 42.69 88.96 60.61 7.85 11.79 7.21 9.32 Other Current Assets 58.62 2.81 2.23 2.40 81.26 436.80 840.56 50.50 85.75 53.01 Short Term Loans & Adv. 55.40 49.72 25.28 51.17 36.90 26.95 31.20 40.95 72.01 44.39 Net Current Assets -57.67 -65.65 -51.72 4.67 93.03 446.97 -4.98 -331.62 -180.53 -132.89 Total Assets 880.95 925.26 889.38 893.32 961.76 1,307.23 1,593.02 1,821.69 1,920.07 1,977.62

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 834.79 842.05 843.60 876.64 -228.69 198.79 350.40 308.68 355.68 448.61 Share Capital 6.13 6.13 6.13 6.13 6.13 6.13 6.13 6.13 6.13 22.43 Total Reserves 828.66 835.92 837.48 870.51 -234.82 160.66 344.27 302.55 349.55 426.18 Non-Current Liabilities 103.62 265.09 270.70 85.10 959.99 740.66 70.08 591.13 718.78 1,100.11 Secured Loans 0.00 0.00 0.18 0.24 675.05 583.55 8.90 560.45 704.57 866.08 Unsecured Loans 22.21 20.99 19.98 33.87 60.03 29.58 37.22 10.26 9.49 1.00 Long Term Provisions 46.82 199.27 198.02 29.16 30.65 42.74 39.78 26.54 18.36 184.42 Current Liabilities 366.99 308.98 329.73 773.77 449.09 622.14 938.26 695.52 689.13 474.80 Trade Payables 225.76 145.56 177.32 234.72 246.66 198.85 269.71 277.19 248.60 187.87 Other Current Liabilities 104.87 127.60 115.71 503.01 189.06 242.12 585.25 242.00 237.52 93.60 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 3.57 69.39 164.88 190.71 191.82 Short Term Provisions 36.37 35.82 36.70 36.03 13.37 177.60 13.92 11.44 12.30 1.51 Total Liabilities 1,301.23 1,412.30 1,440.54 1,732.53 1,177.39 1,558.55 1,355.73 1,592.38 1,774.13 2,024.60 Net Block 551.12 569.26 599.95 622.07 608.70 657.39 805.56 948.97 1,001.37 1,071.11 Gross Block 1,327.84 1,311.87 1,330.83 1,313.94 1,266.39 1,282.22 1,392.90 1,605.84 1,600.07 1,620.29 Accumulated Depreciation 776.73 742.62 730.88 691.87 657.69 624.84 587.34 656.87 598.70 549.18 Non Current Assets 756.05 926.83 874.32 744.57 666.41 875.27 847.84 1,027.55 1,070.91 1,475.22 Capital Work in Progress 128.05 101.50 42.32 17.26 34.42 24.01 22.51 39.92 30.41 115.78 Non Current Investment 0.07 0.07 0.07 0.07 0.07 5.58 5.33 5.25 7.01 5.19 Long Term Loans & Adv. 58.01 242.44 228.23 21.46 17.62 187.70 13.33 28.01 22.03 236.71 Other Non Current Assets 3.01 0.97 3.74 83.71 5.61 0.60 1.12 5.39 10.09 1.26 Current Assets 545.18 485.47 562.32 950.55 510.97 683.27 507.89 564.83 703.22 549.38 Current Investments 3.15 40.36 13.42 5.00 0.00 0.00 0.00 2.03 0.27 3.52 Inventories 213.67 177.94 202.09 212.72 174.14 147.69 81.43 334.21 315.55 305.24 Sundry Debtors 72.56 57.42 60.09 81.66 84.68 68.52 88.73 136.01 142.17 141.67 Cash & Bank 106.97 122.00 225.99 583.28 135.79 89.75 23.48 23.24 14.13 22.93 Other Current Assets 148.83 11.97 8.41 8.75 116.36 377.31 314.25 69.36 231.09 76.02 Short Term Loans & Adv. 132.89 75.77 52.31 59.15 63.72 41.62 41.02 59.30 56.21 66.76 Net Current Assets 178.19 176.49 232.59 176.79 61.88 61.13 -430.38 -130.69 14.08 74.58 Total Assets 1,301.23 1,412.30 1,436.64 1,695.12 1,177.38 1,558.54 1,355.73 1,592.38 1,774.13 2,024.60

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 3.94 33.07 -10.74 -52.69 38.27 -82.86 107.16 172.06 103.83 97.85 PBT -26.06 4.21 -62.75 -93.58 -12.88 -135.97 37.18 -61.23 -84.04 1.40 Adjustment 29.93 26.75 10.43 35.98 31.82 204.95 -67.89 160.40 184.07 133.41 Changes in Working Capital 1.18 4.00 42.67 5.73 20.30 -143.93 137.45 73.35 -2.52 -57.72 Cash after chg. in Working capital 5.05 34.95 -9.66 -51.87 39.24 -74.96 106.74 172.51 97.51 77.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.11 -1.88 -1.09 -0.82 -0.98 -7.90 0.42 -0.45 6.32 20.76 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -60.60 -46.80 2.41 39.54 -37.32 -18.52 -8.33 -2.73 -17.92 22.74 Net Fixed Assets -32.23 -43.47 -13.92 -26.71 28.01 223.59 488.74 -15.06 -27.48 11.93 Net Investments 0.00 0.00 0.00 0.00 54.26 -51.99 342.34 0.00 49.78 0.00 Others -28.37 -3.33 16.33 66.25 -119.59 -190.12 -839.41 12.33 -40.22 10.81 Cash from Financing Activity 90.07 12.82 9.01 9.83 -7.20 109.39 -98.45 -163.67 -91.06 -128.69 Net Cash Inflow / Outflow 33.41 -0.91 0.67 -3.32 -6.26 8.02 0.37 5.66 -5.15 -8.10 Opening Cash & Equivalents 5.09 6.01 5.33 8.66 14.91 4.96 6.52 0.86 6.01 14.13 Closing Cash & Equivalent 38.50 5.09 6.01 5.33 8.66 14.91 4.96 6.52 0.86 6.04

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -27.37 3.47 -422.45 -108.45 106.76 -30.47 104.80 118.02 130.67 90.69 PBT -7.95 1.48 12.81 1,449.36 -145.03 -177.34 46.23 -66.14 -67.18 -18.93 Adjustment -9.87 -5.74 -95.87 -1,454.97 230.88 253.04 -70.58 166.62 149.57 148.75 Changes in Working Capital -8.58 10.23 -336.91 300.86 21.91 -97.50 127.32 21.45 43.32 -58.26 Cash after chg. in Working capital -26.40 5.97 -419.98 295.25 107.76 -21.80 102.97 121.93 125.71 71.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.97 -2.51 -2.48 -403.70 -1.00 -8.67 1.83 -3.91 4.96 19.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 64.98 6.66 430.33 1,282.57 -47.68 -34.76 -5.27 55.29 -25.83 16.44 Net Fixed Assets -32.23 -43.47 -13.92 -26.71 28.01 223.59 488.74 -15.06 -27.48 11.93 Net Investments 0.00 0.00 0.00 0.00 54.26 -51.99 342.34 0.00 49.78 0.00 Others 97.21 50.13 444.25 1,309.28 -129.95 -206.36 -836.35 70.35 -48.13 4.51 Cash from Financing Activity -2.66 -2.81 -18.37 -1,175.84 -47.11 90.74 -101.14 -164.35 -106.96 -117.38 Net Cash Inflow / Outflow 34.95 7.32 -10.49 -1.72 11.97 25.51 -1.61 8.97 -2.13 -10.25 Opening Cash & Equivalents 47.17 39.85 50.35 52.08 40.22 14.47 16.44 7.47 9.59 19.97 Closing Cash & Equivalent 82.13 47.17 39.85 50.35 52.08 40.22 14.47 16.44 7.47 9.73

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 51.26 53.74 53.17 67.77 82.97 140.53 68.32 63.36 74.42 18.54 ROA -1.69% 0.39% -9.57% -9.88% -1.27% -10.56% 1.56% -3.84% -3.73% 0.04% ROE -4.74% 1.08% -23.64% -20.27% -2.11% -23.93% 6.59% -17.03% -25.52% 0.77% ROCE -2.13% 4.08% -11.36% -16.14% -0.70% 1.09% 11.51% 2.96% 1.48% 10.15% Fixed Asset Turnover 0.37 0.43 0.30 0.28 0.41 0.50 0.34 0.38 0.36 0.42 Receivable days 18.71 11.82 25.11 45.26 27.77 15.98 68.81 100.51 106.68 68.41 Inventory Days 152.40 113.44 173.06 167.03 97.64 52.82 78.73 91.54 92.98 78.23 Payable days 499.26 315.92 306.74 437.99 269.16 104.62 146.14 199.79 153.09 120.20 Cash Conversion Cycle -328.15 -190.66 -108.57 -225.70 -143.75 -35.82 1.40 -7.74 46.57 26.45 Total Debt/Equity 0.73 0.38 0.31 0.20 0.13 0.08 1.65 2.50 2.24 7.84 Interest Cover -0.69 1.31 -5.24 -12.29 -0.71 0.08 1.36 0.41 0.19 1.01

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 136.29 137.48 137.73 143.12 -37.34 27.23 57.21 50.40 58.07 -4.43 ROA -0.64% -0.11% -2.12% 74.05% -10.69% -13.36% 2.55% -4.53% -2.97% -1.01% ROE -1.04% -0.18% -3.92% 332.85% 0.00% -75.26% 11.39% -22.94% -34.38% 0.00% ROCE -0.47% 0.59% 1.94% 217.12% 5.36% -0.38% 13.44% 2.63% 2.76% 9.93% Fixed Asset Turnover 0.43 0.43 0.36 0.54 0.51 0.41 0.30 0.37 0.35 0.40 Receivable days 42.20 37.70 54.62 43.66 42.68 52.75 89.81 85.16 92.84 67.10 Inventory Days 127.15 121.93 159.84 101.55 89.66 76.86 166.09 198.91 203.06 171.89 Payable days 339.61 256.06 297.63 335.05 397.33 178.20 213.56 186.55 163.89 130.73 Cash Conversion Cycle -170.26 -96.42 -83.17 -189.84 -264.98 -48.60 42.34 97.52 132.00 108.26 Total Debt/Equity 0.03 0.02 0.02 0.04 -3.58 4.45 1.85 3.05 2.79 -100.22 Interest Cover -1.05 1.41 3.89 9.01 0.22 -0.02 1.44 0.34 0.33 0.85

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Panacea Biotec gets LoA worth Rs 127.2 crore
9th Oct 2025, 15:58 PM

The company will supply the vaccine in several tranches over a period of 90-480 days from the date of issuance of LoA
Read More
Panacea Biotec gets LoA worth Rs 315 crore
3rd Oct 2025, 15:19 PM

The LoA is for a long-term agreement for supply of bivalent oral polio vaccine (bOPV) to UNICEF
Read More
Panacea Biotec - Quarterly Results
14th Aug 2025, 18:25 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback